Placebo (for memantine)

DRUG2 trials

Sponsors

University of Kansas Medical Center, University of Utah

Conditions

Amyotrophic Lateral SclerosisFrontal Temporal DementiaIschemic StrokeUpper Extremity Weakness

Early Phase 1

Memantine for Enhanced Stroke Recovery

Active, not recruitingNCT02144584

University of UtahIschemic Stroke, Upper Extremity Weakness

Start: 2014-01-01End: 2027-06-01Target: 20Updated: 2026-08-27

Phase 2

Therapy in Amyotrophic Lateral Sclerosis (TAME)

CompletedNCT02118727

University of Kansas Medical CenterAmyotrophic Lateral Sclerosis, Frontal Temporal Dementia

Start: 2018-11-07End: 2021-07-22Updated: 2022-11-29